John M Gross, Ying S Zou, Michael Michal, Abbas Agaimy, Roberto A Garcia, Christopher Hysell, Karen J Fritchie, Josephine K Dermawan, Brian P Rubin, Melanie Klausner, Laura Morsberger, Jonathan Dudley, Alyza Skaist, Yan Zhang, Kornel Schuebel, Jennifer Meyers, Srinivasan Yegnasubramanian, Leslie Cope, Nasir Ud Din, Ali Alani, David I Suster, Lisa Rooper, Pedram Argani, Ezra G Baraban, Daniel Baumhoer, Baptiste Ameline, Gregory W Charville, Andrew E Rosenberg
{"title":"骨化纺锤状上皮样肿瘤:一种新的软组织肿瘤。","authors":"John M Gross, Ying S Zou, Michael Michal, Abbas Agaimy, Roberto A Garcia, Christopher Hysell, Karen J Fritchie, Josephine K Dermawan, Brian P Rubin, Melanie Klausner, Laura Morsberger, Jonathan Dudley, Alyza Skaist, Yan Zhang, Kornel Schuebel, Jennifer Meyers, Srinivasan Yegnasubramanian, Leslie Cope, Nasir Ud Din, Ali Alani, David I Suster, Lisa Rooper, Pedram Argani, Ezra G Baraban, Daniel Baumhoer, Baptiste Ameline, Gregory W Charville, Andrew E Rosenberg","doi":"10.1016/j.modpat.2025.100840","DOIUrl":null,"url":null,"abstract":"<p><p>This investigation describes the clinicoradiologic, pathologic, and molecular features of a unique soft tissue tumor characterized by a peripheral shell of bone and composed of bland myoid spindle and epithelioid cells that are keratin-positive. Our study cohort consists of 6 males and 6 females with a mean age of 32 years. The tumors arose in the extremities (n=9) and proximal limb girdle (n=3) and were equally distributed between deep and superficial soft tissues. Patients reported dull painless masses of several months to greater than 10 years duration (mean: 2.9 yrs). Imaging demonstrated a complete or partial peripheral shell of bone that could extend centrally, and the tumor mean size was 5.7 cm. Histologically, the tumors were composed of uniform eosinophilic myoid spindled cells growing in sheets and intersecting fascicles surrounded by mature lamellar and/or woven bone. Also present was an admixed component of intermediate-sized epithelioid cells with eosinophilic cytoplasm. Mitotic activity was consistently low. Immunohistochemistry showed strong multifocal staining for keratins and 50% (5/10) showed focal staining for S100; however, all were negative for SMA, desmin, SOX10, ERG, and CD34. Genetic analysis by multiple targeted RNA sequencing panels was negative (n=10); however, whole transcriptome sequencing (WTS) (n=8) revealed a recurrent and novel in-frame SRSF7::NFATC3 fusion in four tumors. Dual FISH probes for SRSF7::NFATc3 successfully confirmed this fusion and identified a 5<sup>th</sup> case which had not undergone WTS but was negative by a targeted RNA fusion panel. Methylation profiling (n=8) demonstrated a shared epigenetic profile distinct from other entities. Clinical follow-up (n=11) showed no evidence of recurrence after primary excision with a mean of 41.6 months. In summary, we describe a novel soft tissue tumor designated 'ossifying spindled and epithelioid tumor' (OSET) as a descriptive histologic term that also emphasizes its close radiologic mimic, ossifying fibromyxoid tumor (OFMT). All cases have behaved in a benign fashion without recurrence following simple excision. Awareness of this entity is important so it can be distinguished from other neoplasms that have more aggressive biological potential.</p>","PeriodicalId":18706,"journal":{"name":"Modern Pathology","volume":" ","pages":"100840"},"PeriodicalIF":7.1000,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ossifying Spindled and Epithelioid Tumor: A Novel Soft Tissue Tumor.\",\"authors\":\"John M Gross, Ying S Zou, Michael Michal, Abbas Agaimy, Roberto A Garcia, Christopher Hysell, Karen J Fritchie, Josephine K Dermawan, Brian P Rubin, Melanie Klausner, Laura Morsberger, Jonathan Dudley, Alyza Skaist, Yan Zhang, Kornel Schuebel, Jennifer Meyers, Srinivasan Yegnasubramanian, Leslie Cope, Nasir Ud Din, Ali Alani, David I Suster, Lisa Rooper, Pedram Argani, Ezra G Baraban, Daniel Baumhoer, Baptiste Ameline, Gregory W Charville, Andrew E Rosenberg\",\"doi\":\"10.1016/j.modpat.2025.100840\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This investigation describes the clinicoradiologic, pathologic, and molecular features of a unique soft tissue tumor characterized by a peripheral shell of bone and composed of bland myoid spindle and epithelioid cells that are keratin-positive. Our study cohort consists of 6 males and 6 females with a mean age of 32 years. The tumors arose in the extremities (n=9) and proximal limb girdle (n=3) and were equally distributed between deep and superficial soft tissues. Patients reported dull painless masses of several months to greater than 10 years duration (mean: 2.9 yrs). Imaging demonstrated a complete or partial peripheral shell of bone that could extend centrally, and the tumor mean size was 5.7 cm. Histologically, the tumors were composed of uniform eosinophilic myoid spindled cells growing in sheets and intersecting fascicles surrounded by mature lamellar and/or woven bone. Also present was an admixed component of intermediate-sized epithelioid cells with eosinophilic cytoplasm. Mitotic activity was consistently low. Immunohistochemistry showed strong multifocal staining for keratins and 50% (5/10) showed focal staining for S100; however, all were negative for SMA, desmin, SOX10, ERG, and CD34. Genetic analysis by multiple targeted RNA sequencing panels was negative (n=10); however, whole transcriptome sequencing (WTS) (n=8) revealed a recurrent and novel in-frame SRSF7::NFATC3 fusion in four tumors. Dual FISH probes for SRSF7::NFATc3 successfully confirmed this fusion and identified a 5<sup>th</sup> case which had not undergone WTS but was negative by a targeted RNA fusion panel. Methylation profiling (n=8) demonstrated a shared epigenetic profile distinct from other entities. Clinical follow-up (n=11) showed no evidence of recurrence after primary excision with a mean of 41.6 months. In summary, we describe a novel soft tissue tumor designated 'ossifying spindled and epithelioid tumor' (OSET) as a descriptive histologic term that also emphasizes its close radiologic mimic, ossifying fibromyxoid tumor (OFMT). All cases have behaved in a benign fashion without recurrence following simple excision. Awareness of this entity is important so it can be distinguished from other neoplasms that have more aggressive biological potential.</p>\",\"PeriodicalId\":18706,\"journal\":{\"name\":\"Modern Pathology\",\"volume\":\" \",\"pages\":\"100840\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2025-07-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Modern Pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.modpat.2025.100840\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.modpat.2025.100840","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
Ossifying Spindled and Epithelioid Tumor: A Novel Soft Tissue Tumor.
This investigation describes the clinicoradiologic, pathologic, and molecular features of a unique soft tissue tumor characterized by a peripheral shell of bone and composed of bland myoid spindle and epithelioid cells that are keratin-positive. Our study cohort consists of 6 males and 6 females with a mean age of 32 years. The tumors arose in the extremities (n=9) and proximal limb girdle (n=3) and were equally distributed between deep and superficial soft tissues. Patients reported dull painless masses of several months to greater than 10 years duration (mean: 2.9 yrs). Imaging demonstrated a complete or partial peripheral shell of bone that could extend centrally, and the tumor mean size was 5.7 cm. Histologically, the tumors were composed of uniform eosinophilic myoid spindled cells growing in sheets and intersecting fascicles surrounded by mature lamellar and/or woven bone. Also present was an admixed component of intermediate-sized epithelioid cells with eosinophilic cytoplasm. Mitotic activity was consistently low. Immunohistochemistry showed strong multifocal staining for keratins and 50% (5/10) showed focal staining for S100; however, all were negative for SMA, desmin, SOX10, ERG, and CD34. Genetic analysis by multiple targeted RNA sequencing panels was negative (n=10); however, whole transcriptome sequencing (WTS) (n=8) revealed a recurrent and novel in-frame SRSF7::NFATC3 fusion in four tumors. Dual FISH probes for SRSF7::NFATc3 successfully confirmed this fusion and identified a 5th case which had not undergone WTS but was negative by a targeted RNA fusion panel. Methylation profiling (n=8) demonstrated a shared epigenetic profile distinct from other entities. Clinical follow-up (n=11) showed no evidence of recurrence after primary excision with a mean of 41.6 months. In summary, we describe a novel soft tissue tumor designated 'ossifying spindled and epithelioid tumor' (OSET) as a descriptive histologic term that also emphasizes its close radiologic mimic, ossifying fibromyxoid tumor (OFMT). All cases have behaved in a benign fashion without recurrence following simple excision. Awareness of this entity is important so it can be distinguished from other neoplasms that have more aggressive biological potential.
期刊介绍:
Modern Pathology, an international journal under the ownership of The United States & Canadian Academy of Pathology (USCAP), serves as an authoritative platform for publishing top-tier clinical and translational research studies in pathology.
Original manuscripts are the primary focus of Modern Pathology, complemented by impactful editorials, reviews, and practice guidelines covering all facets of precision diagnostics in human pathology. The journal's scope includes advancements in molecular diagnostics and genomic classifications of diseases, breakthroughs in immune-oncology, computational science, applied bioinformatics, and digital pathology.